To explore the advancements and clinical applicability of robotic-assisted percutaneous coronary intervention (rPCI) compared to manual percutaneous coronary intervention (mPCI).
Approach:
Introduction to mPCI and rPCI: Describes the conventional PCI process and the transition to robotic-assisted techniques, highlighting the occupational risks associated with mPCI and the potential benefits of rPCI.
Clinical Applicability of rPCI: Details the procedural approach of rPCI, emphasizing the use of robotic platforms for device manipulation and the advantages for operator ergonomics and radiation exposure.
Procedural Results and Technical Success: Summarizes findings from pivotal studies like PRECISE and CORA-PCI, showcasing high procedural success rates and the ability to treat complex lesions with rPCI.
Key Findings:
The PRECISE study reported a 97.6% procedural success rate for low-complexity lesions using the CorPath 200 system.
The CORA-PCI study demonstrated rPCI's applicability across a spectrum of coronary interventions, including complex lesions.
Manual support was required in 19.9% of cases using the second-generation CorPath GRX System, particularly for complex lesions.
Interpretation:
Robotic-assisted PCI shows promise in reducing operator radiation exposure and improving ergonomics, though it may require manual assistance in complex cases and results in longer procedural times.
Limitations:
Manual support is still needed in a significant proportion of cases, particularly for complex lesions.
Procedural times are longer for rPCI compared to mPCI.
Conclusion:
Robotic-assisted PCI has potential advantages over manual techniques, but further evaluation is needed to fully assess its efficacy and efficiency in various clinical scenarios.
